Statistics for Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

Total visits

views
Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00 0

Total visits per month

views
September 2025 0
October 2025 0
November 2025 0
December 2025 0
January 2026 0
February 2026 0
March 2026 0